Nabla Valuation Multiples

Nabla is valued at $23M as of October 2026, a 1.3x revenue multiple. In the last fiscal year, Nabla revenue was $16M and Nabla EBITDA was $2M.

See full Nabla profile

Nabla Overview

About Nabla

Nabla SpA is an Italian makeup company that develops and markets makeup products and accessories, prominently in the face, eye, lip, and accessories categories, through an omnichannel distribution model that combines direct digital channels, marketplaces, and partnerships with select retailers. The company's product offering is divided into the following macro-categories: (i) face, (ii) eyes, (iii) lips and (iv) accessories.


Founded

2013

HQ

Italy

Employees

N/A

Financials (Last FY)

Revenue: $16M
EBITDA: $2M

EV

$21M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nabla Financials

Nabla reported last fiscal year revenue of $16M and EBITDA of $2M.

In the same fiscal year, Nabla generated $11M in gross profit, $2M in EBITDA, and $2M in net income.


Nabla P&L

In the most recent fiscal year, Nabla reported revenue of $16M and EBITDA of $2M.

Nabla is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 15%, and net margin of 10%.

See analyst estimates for Nabla
Last FY20242025202620272028
Revenue$16M$14M$16M
Gross Profit$11M$9M$11M
Gross Margin67%62%67%
EBITDA$2M$2M$2M
EBITDA Margin15%14%15%
EBIT Margin10%13%10%
Net Profit$2M$1M$2M
Net Margin10%9%10%
Net Debt($2M)--

Financial data powered by Morningstar, Inc.

Nabla Stock Performance

Nabla has current market cap of $23M, and enterprise value of $21M.

Market Cap Evolution


Nabla's stock price is $3.46.

Nabla share price increased by 0.7% in the last 30 days.

Nabla has an EPS (earnings per share) of $0.25.

See more trading valuation data for Nabla
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$21M$23M2.0%0.7%--$0.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nabla Valuation Multiples

Nabla trades at 1.3x EV/Revenue multiple, and 8.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Nabla

Nabla Financial Valuation Multiples

As of October 8, 2026, Nabla has market cap of $23M and EV of $21M.

Nabla has a P/E ratio of 13.8x.

Last FY20242025202620272028
EV/Revenue1.3x1.5x1.3x
EV/EBITDA8.6x10.4x8.6x
EV/EBIT13.4x11.6x13.4x
EV/Gross Profit1.9x2.4x1.9x
P/E13.8x18.0x13.8x
EV/FCF7.6x(12.9x)7.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nabla Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nabla Margins & Growth Rates

In the most recent fiscal year, Nabla reported gross margin of 67%, EBITDA margin of 15%, and net margin of 10%.

See estimated margins and future growth rates for Nabla

Nabla Margins

Last FY20242025202720282029
Gross Margin67%62%67%
EBITDA Margin15%14%15%
EBIT Margin10%13%10%
Net Margin10%9%10%
FCF Margin17%(11%)17%

Nabla Growth Rates

24/2526/2727/2828/29
Revenue Growth15%
Gross Profit Growth24%
EBITDA Growth22%
EBIT Growth(14%)
Net Profit Growth30%
FCF Growth(270%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Nabla Operational KPIs

Access forward-looking KPIs for Nabla
Last FY20242025202620272028
S&M Expenses to Revenue22%18%22%
G&A Expenses to Revenue0%6%0%
R&D Expenses to Revenue0%1%0%
Opex to Revenue58%49%58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nabla Competitors

Nabla competitors include Promisia Healthcare, Delko, Big Tree Cloud Holdings, Cosma, Jacques Bogart, SFD, McPherson's, Lavena - Shumen, EZZ Life Science and Nuchev.

Most Nabla public comparables operate across Health & Beauty.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Promisia Healthcare$21M$10M4.4x-9.3x-
Delko$201M$7M0.2x-5.8x-
Big Tree Cloud Holdings$3M($31M)5.9x-(0.5x)-
Cosma$4M($2M)3.5x-(6.2x)-
Jacques Bogart$298M$25M0.7x-8.8x-
SFD$113M$3M0.4x-12.7x-
McPherson's$97M($9M)0.1x0.2x(1.6x)2.9x
Lavena - Shumen$15M$2M0.8x-5.2x-

This data is available for Pro users. Sign up to see all Nabla competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nabla

When was Nabla founded?Nabla was founded in 2013.
Where is Nabla headquartered?Nabla is headquartered in Italy.
Is Nabla publicly listed?Yes, Nabla is a public company listed on Borsa Italiana.
What is the stock symbol of Nabla?Nabla trades under NABLA ticker.
When did Nabla go public?Nabla went public in 2026.
Who are competitors of Nabla?Nabla main competitors include Promisia Healthcare, Delko, Big Tree Cloud Holdings, Cosma, Jacques Bogart, SFD, McPherson's, Lavena - Shumen, EZZ Life Science, Nuchev.
What is the current market cap of Nabla?Nabla's current market cap is $23M.
What is the current revenue of Nabla?Nabla's last fiscal year revenue is $16M.
What is the current EV/Revenue multiple of Nabla?Current revenue multiple of Nabla is 1.3x.
Is Nabla profitable?No, Nabla is not profitable.
How many companies Nabla has acquired to date?Nabla hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nabla has invested to date?Nabla hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nabla

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial